GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (NAS:NUWE) » Definitions » EV-to-EBITDA
中文

Nuwellis (Nuwellis) EV-to-EBITDA : 0.05 (As of Apr. 25, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Nuwellis EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nuwellis's enterprise value is $-0.76 Mil. Nuwellis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-16.36 Mil. Therefore, Nuwellis's EV-to-EBITDA for today is 0.05.

The historical rank and industry rank for Nuwellis's EV-to-EBITDA or its related term are showing as below:

NUWE' s EV-to-EBITDA Range Over the Past 10 Years
Min: -122.42   Med: 0.18   Max: 3.01
Current: 0.05

During the past 13 years, the highest EV-to-EBITDA of Nuwellis was 3.01. The lowest was -122.42. And the median was 0.18.

NUWE's EV-to-EBITDA is ranked better than
98.36% of 487 companies
in the Medical Devices & Instruments industry
Industry Median: 15.1 vs NUWE: 0.05

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), Nuwellis's stock price is $0.2521. Nuwellis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.615. Therefore, Nuwellis's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nuwellis EV-to-EBITDA Historical Data

The historical data trend for Nuwellis's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuwellis EV-to-EBITDA Chart

Nuwellis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.18 -0.30 0.58 2.36 -0.03

Nuwellis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.36 0.83 0.42 0.23 -0.03

Competitive Comparison of Nuwellis's EV-to-EBITDA

For the Medical Devices subindustry, Nuwellis's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuwellis's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nuwellis's EV-to-EBITDA falls into.



Nuwellis EV-to-EBITDA Calculation

Nuwellis's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-0.755/-16.356
=0.05

Nuwellis's current Enterprise Value is $-0.76 Mil.
Nuwellis's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuwellis  (NAS:NUWE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nuwellis's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.2521/-12.615
=At Loss

Nuwellis's share price for today is $0.2521.
Nuwellis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.615.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nuwellis EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nuwellis's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuwellis (Nuwellis) Business Description

Traded in Other Exchanges
Address
12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
Executives
David Mcdonald director 6 KEMPTON PLACE, #12, SARATOGA SPRINGS NY 12866
Archelle Georgiou Feldshon director 1420 SHORELINE DRIVE, WAYZATA MN 55391
Robert Benjamin Scott officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Kendrick Mccormick director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Gregory D Waller director 1717 W COLLINS AVENUE, ORANGE CA 92867
Jon W Salveson director 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Nestor Jr. Jaramillo officer: Chief Commercial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Lynn Larson Blake officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
George Montague officer: CFO and Treasurer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Neil P Ayotte officer: SVP, Secretary, GC & CCO 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Paul Wotta officer: Principal Accounting Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Claudia Drayton officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Thomas P. Lynch officer: Chief Legal/Compliance Officer 3344 N. TORREY PINES COURT, LA JOLLA CA 92037
Steven Frank Brandt director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Maria Rosa Costanzo director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344